Stockscreener 앱 받기
1.72
9.55%
0.15
시장 영업 전:
1.72
전일 마감가:
$1.57
열려 있는:
$1.59
하루 거래량:
54,125
Relative Volume:
0.02
시가총액:
$7.74M
수익:
$9.37M
순이익/손실:
$-8.45M
주가수익비율:
-2.1235
EPS:
-0.81
순현금흐름:
$-7.27M
1주 성능:
+18.62%
1개월 성능:
-17.70%
6개월 성능:
-81.08%
1년 성능:
-94.54%
1일 변동 폭
$1.55
$1.73
1주일 범위
$1.34
$1.73
52주 변동 폭
$1.25
$46.53
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
명칭
Bioaffinity Technologies Inc
전화
210-698-5334
주소
3300 NACOGDOCHES ROAD, SAN ANTONIO
BIAF을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
1.72 | 7.06M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
575.24 | 218.08B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
227.13 | 161.37B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
717.35 | 57.97B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
148.32 | 42.25B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
224.92 | 38.70B | 15.90B | 1.28B | 2.21B | 7.2842 |
Bioaffinity Technologies Inc 주식(BIAF)의 최신 뉴스
Why bioAffinity Technologies Inc. stock could outperform in 2025CPI Data & Daily Profit Maximizing Tips - Newser
bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society - PharmiWeb.com
bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable - BioSpace
bioAffinity Technologies to Present at Cancer Roundtable - TipRanks
bioAffinity Technologies, Inc. to Present CyPath® Lung Test at ACS Roundtable - TradingView
Certain Warrants of bioAffinity Technologies, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - MarketScreener
Certain Convertible Preferred Stock of bioAffinity Technologies, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - marketscreener.com
1,375,102 Common Stock of bioAffinity Technologies, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - marketscreener.com
bioAffinity Technologies Inc trading halted, volatility trading pause - MSN
WallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules (PR Newswire) - Aktiellt
bioAffinity Technologies Inc. (BIAF) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Aug Action: Why bioAffinity Technologies Inc. stock could be next big winner - BỘ NỘI VỤ
bioAffinity Technologies Reports Strong Growth in Lung Test Revenue - MSN
How bioAffinity Technologies Inc. stock benefits from global expansionGDP Growth & Fast Exit Strategy with Risk Control - moha.gov.vn
Investment Review: Why retail investors pile into bioAffinity Technologies Inc. stockJuly 2025 Analyst Calls & Risk Controlled Daily Trade Plans - moha.gov.vn
Earnings roundup: Q3 rocky for bioAffinity and Spurs concessionaire - San Antonio Express-News
Is bioAffinity Technologies Inc Equity Warrant a good long term investmentMean Reversion Trades & Rapid Portfolio Gain - earlytimes.in
BIAF Stock Dips After Q3 Earnings Reflect Lower Sales and Wider Loss - MSN
bioAffinity Technologies Reports Surge in CyPath® Lung Tests - MSN
How bioAffinity Technologies Inc. stock benefits from tech adoptionJuly 2025 Momentum & Weekly Breakout Stock Alerts - newser.com
Is bioAffinity Technologies Inc. stock cheap compared to fundamentalsTrade Volume Summary & Weekly Stock Breakout Alerts - newser.com
Will bioAffinity Technologies Inc. stock deliver strong dividend growthWeekly Volume Report & Real-Time Market Sentiment Reports - newser.com
Will bioAffinity Technologies Inc. stock recover faster than marketJuly 2025 Update & AI Optimized Trading Strategy Guides - newser.com
Is bioAffinity Technologies Inc. stock a buy for dividend growth2025 Short Interest & Accurate Technical Buy Alerts - newser.com
Volume spikes in bioAffinity Technologies Inc. Equity Warrant stock – what they mean2025 Volatility Report & Growth Focused Entry Point Reports - newser.com
Is bioAffinity Technologies Inc. meeting your algorithmic filter criteriaProduct Launch & Fast Exit and Entry Strategy Plans - newser.com
Is bioAffinity Technologies Inc. stock oversold or undervaluedTrade Exit Summary & AI Based Buy and Sell Signals - newser.com
Maxim Group Sticks to Its Buy Rating for bioAffinity Technologies, Inc. (BIAF) - The Globe and Mail
Will bioAffinity Technologies Inc. Equity Warrant benefit from macro trendsPortfolio Return Report & AI Enhanced Execution Alerts - newser.com
Why bioAffinity Technologies Inc. stock is seen as undervalued2025 Institutional Moves & Verified Swing Trading Watchlists - newser.com
Will bioAffinity Technologies Inc. stock see insider buying2025 Top Gainers & Technical Confirmation Trade Alerts - newser.com
What recovery options are there for bioAffinity Technologies Inc.2025 Sector Review & Fast Exit/Entry Strategy Plans - newser.com
Is bioAffinity Technologies Inc. stock attractive for retirement portfoliosJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - newser.com
Using data filters to optimize entry into bioAffinity Technologies Inc. Equity WarrantJuly 2025 PreEarnings & Reliable Intraday Trade Alerts - newser.com
MSN Money - MSN
Is bioAffinity Technologies Inc. stock attractive for growth ETFs2025 Historical Comparison & Free Growth Oriented Trading Recommendations - newser.com
Can momentum traders help lift bioAffinity Technologies Inc. Equity WarrantMarket Movement Recap & Daily Chart Pattern Signal Reports - newser.com
Will bioAffinity Technologies Inc. Equity Warrant stock outperform Dow Jones indexMarket Activity Report & High Accuracy Investment Signals - newser.com
Will bioAffinity Technologies Inc. Equity Warrant stock beat EPS estimatesMarket Performance Summary & Risk Managed Trade Strategies - newser.com
Bioaffinity Technologies Inc (BIAF) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.86%
1.61%
자본화:
|
볼륨(24시간):